Press Releases

The Application of Reporter Cell Line in The Treatment of Drug Discovery of Various Disease

BioIVT and Mawi DNA Technologies Describe Successful COVID-19 Supply Chain Solutions

The companies explain how they enhanced biospecimen collection and COVID-19 testing methods to meet pandemic demands.

Qvirus Launches Lentivirus Integration Site Analysis Service to Support Identifying Target Site of Recombinant Lentiviral Vectors

Irish Company Develops Cloud-Based App Aimed to Accelerate Global COVID-19 Vaccination Process

Pharmapod has developed the Clinical Services app cloud-based solution to simplify every step of the vaccine rollout.

VERICHEM LABORATORIES OFFERS FREE CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM now furnishes all customers free access to the company’s online, web-based, data reduction services which is specifically designed for use with the company's broad line of clinical reference materials.

News Update: MedAI Integrates AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery

Earlier this month, MedAI announces that it has integrated its three AI-powered drug discovery platforms so as to increase drug candidate efficacy and safety throughout the preclinical research. Previously, the company has released AIDD Platform, CADD Platform, and Experimental Validation Platform, which consist of proprietary hardware, biological, molecular and digital technologies.

News Update: Custom Pharmaceutical Excipients Development Service Available at Formulationbio

Known as not only a provider of various excipients but also a CRO for pharmaceutical formulation, Formulationbio announces to provide tailor-made pharmaceutical excipients development service for customers across the globe on April 20, 2021.

Pronalyse Anounces PEGylated Protein Identification Methods for Drug Discovery

Alfa Chemistry Released Four Types of Featured Products for the Research Community

In an effort to combine what the customers truly need and what the company provides, Alfa Chemistry recently sorted and released four types of featured products for scientists and researchers who are engaged with the tumor, coronavirus, and flu treatment research as well as the production of personal daily care products.

Applied Photophysics celebrates 50 years

Applied Photophysics, a leading provider of solutions for biophysical characterization of biomolecules, celebrates 50 years in the biopharmaceutical industry.

MicrobioSeq Division Releases Microbial Single-Cell Genome Sequencing to Reveal Heterogeneity of Microbial Populations

Microarray Data Analysis Methods Are Now Available at Bioinformatics-Analysis Division of CD Genomics

GutFlora Omics Platform Releases Total RNA Sequencing Service

Alfa Chemistry Launches a New Sub-Website for the Supply of Graphene and Related CRO Service

Currently graphene has been widely used in modern technology. In order to make graphene products and related CRO services more accessible to scientists and researchers worldwide, Alfa Chemistry announces to have established a new sub-website earlier this month in 2021.

COVID-19 driving manufacturing and CDMOs driving growth per executive survey

Lifeasible Offers a Wide Scope of Feed Testing Services to Ensure Feed Safety and Quality

Profacgen Announced the Release of Protein Lyophilization Service to Assist Protein Research

Isohelix and AutoGen sign a collaborative supply agreement

Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation, have signed a far-reaching supply agreement.

CytoSMART redefines automated cell counting with a new fluorescence cell counter

Today CytoSMART Technologies has announced the release of its first fluorescence cell counter, CytoSMART Exact FL

MedAI Launches Integrated Drug Discovery Approaches to Solve In Silico Drug Discovery Problems

MedAI announces that it has launched integrated drug discovery approaches to help to solve in silico drug discovery challenges, such as problems arising from drug candidate compound screening, target profiling, compound structure scoring in de novo design, and other related calculations.